罕少疾病杂志
罕少疾病雜誌
한소질병잡지
Journal of Rare and Uncommon Diseases
2015年
5期
28-29,32
,共3页
缬沙坦胶囊%前列地尔注射液%糖尿病肾病
纈沙坦膠囊%前列地爾註射液%糖尿病腎病
힐사탄효낭%전렬지이주사액%당뇨병신병
Valsartan Capsules%Alprostadil Injection%Diabetic Nephropathy
目的:研究缬沙坦胶囊联合前列地尔注射液对糖尿病肾病的治疗效果。方法研究年限为2013年12月-2014年12月,对象为肾内科收入治疗的30例糖尿病肾病患者,基于治疗方式划分成对照组(15例,缬沙坦胶囊治疗)和观察组(15例,缬沙坦胶囊联合前列地尔注射液治疗);对照研究两组患者的临床治疗效果及肾功能改善情况。结果两组患者治疗后空腹血糖、糖化血糖蛋白、舒张压、收缩压、尿蛋白排泄率、血肌酐值、尿素氮、ACR等指标经统计学t检验,P均<0.05,具有显著差异性。结论缬沙坦胶囊联合前列地尔注射液可有效改善糖尿病肾病患者的肾功能,降低尿蛋白排泄,稳定血压和血糖,疗效显著,建议在临床中优先选择使用。
目的:研究纈沙坦膠囊聯閤前列地爾註射液對糖尿病腎病的治療效果。方法研究年限為2013年12月-2014年12月,對象為腎內科收入治療的30例糖尿病腎病患者,基于治療方式劃分成對照組(15例,纈沙坦膠囊治療)和觀察組(15例,纈沙坦膠囊聯閤前列地爾註射液治療);對照研究兩組患者的臨床治療效果及腎功能改善情況。結果兩組患者治療後空腹血糖、糖化血糖蛋白、舒張壓、收縮壓、尿蛋白排洩率、血肌酐值、尿素氮、ACR等指標經統計學t檢驗,P均<0.05,具有顯著差異性。結論纈沙坦膠囊聯閤前列地爾註射液可有效改善糖尿病腎病患者的腎功能,降低尿蛋白排洩,穩定血壓和血糖,療效顯著,建議在臨床中優先選擇使用。
목적:연구힐사탄효낭연합전렬지이주사액대당뇨병신병적치료효과。방법연구년한위2013년12월-2014년12월,대상위신내과수입치료적30례당뇨병신병환자,기우치료방식화분성대조조(15례,힐사탄효낭치료)화관찰조(15례,힐사탄효낭연합전렬지이주사액치료);대조연구량조환자적림상치료효과급신공능개선정황。결과량조환자치료후공복혈당、당화혈당단백、서장압、수축압、뇨단백배설솔、혈기항치、뇨소담、ACR등지표경통계학t검험,P균<0.05,구유현저차이성。결론힐사탄효낭연합전렬지이주사액가유효개선당뇨병신병환자적신공능,강저뇨단백배설,은정혈압화혈당,료효현저,건의재림상중우선선택사용。
Objective To investigate the treatment efficacy of Valsartan Capsules in combination with Alprostadil Injection to the diabetic nephropathy.Methods The research duration extends from December 2013 to December 2014, 30 patients with diabetic nephropathy were selected as research subjects, who were divided into the control group (15 cases,treatment with Valsartan Capsules) and the observation group (15 cases, Valsartan Capsules combination with Alprostadil Fat Emusiom Injection treatment) based on treatment methods. Clinical treatment efifcacy effects and renal function improvements in two groups were applied with comparative research.Results The fasting glucose, glycosylated protein, diastolic blood pressure, systolic blood pressure and excretion rate of urinary albumin, serum creatinine, urea nitrogen, and ACR indicators of two groups patients had statistic difference, the P<0.05.Conclusions Valsartan Capsules in combination with Alprostadil Injection can effectively improve renal function, reduce urinary protein excretion, and stable blood pressure and blood sugar in the patients of diabetic nephropathy and it is preferred to be used in clinical service.